# \[e-drug\] Therapeutics Letter 40 now on the web **URL:** \ **Category:** e-drug\ **Created:** [June 6, 2001, 8:23pm UTC](https://talk.edrugplus.org/t/e-drug-therapeutics-letter-40-now-on-the-web/11526 "2001-06-06T20:23:43Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Ciprian\_D\_Jauca](https://avatars.discourse-cdn.com/v4/letter/c/a9adbd/32.png) [@Ciprian\_D\_Jauca](https://talk.edrugplus.org/u/Ciprian_D_Jauca)\ **Post date:** [June 6, 2001, 8:23pm UTC](https://talk.edrugplus.org/t/e-drug-therapeutics-letter-40-now-on-the-web/11526/1 "2001-06-06T20:23:43Z")
E-drug: Therapeutics Letter 40 now on the web ------------------------------------------------------------------------- I would like to bring to your attention the March/April 2001 issue (#40) of the Therapeutics Letter: Direct To Consumer Advertising: Finasteride for male pattern hair loss that is now available on the Therapeutics Initiative web-site at [http://www.ti.ubc.ca/pages/letter40.htm](http://www.ti.ubc.ca/pages/letter40.htm) I invite you to drop by and have a look at this Letter. Please feel free to forward this message to any of your friends or colleagues that might be interested in this topic. We would appreciate receiving your comments on this Therapeutics Letter and its possible implications in clinical practice. Best regards, Ciprian D Jauca Program Coordinator Therapeutics Initiative - Evidence Based Drug Therapy University of British Columbia 2176 Health Sciences Mall Vancouver, BC V6T 1Z3 Canada E-mail: jauca@ti.ubc.ca Phone: +1 (604) 822-0700 GSM Mobile Phone: +1 (604) 722-2075 Fax: +1 (604) 822-0701 Web: [http://www.ti.ubc.ca](http://www.ti.ubc.ca) -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Information and archive [http://www.healthnet.org/programs/edrug.html](http://www.healthnet.org/programs/edrug.html) Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.